Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
Cash Provided by (Used in) Operating Activities
Net earnings	$ 3,118	$ 3,772
Adjustments to reconcile net earnings to operating cash flows:
Depreciation and amortization	106	104
Deferred income tax provision (benefit)	(52)	64
Earnings from equity investments	(533)	(570)
Dividends from ABI	221	477
Loss on ABI/SABMiller business combination	0	33
Loss on Cronos-related financial instruments	691	0
Asset impairment and exit costs, net of cash paid	(1)	(16)
Cash effects of changes:
Receivables	(21)	(2)
Inventories	96	105
Accounts payable	(175)	(158)
Income taxes	94	225
Accrued liabilities and other current assets	80	121
Accrued settlement charges	(1,435)	(369)
Pension plan contributions	(14)	(11)
Pension provisions and postretirement, net	(18)	(2)
Other, net	235	77
Net cash provided by (used in) operating activities	2,392	3,850
Cash Provided by (Used in) Investing Activities
Capital expenditures	(79)	(72)
Investment in Cronos	(1,832)	0
Other, net	(65)	(9)
Net cash provided by (used in) investing activities	(1,976)	(81)
Cash Provided by (Used in) Financing Activities
Repayment of short-term borrowings	(12,800)	0
Long-term debt issued	16,265	0
Repurchases of common stock	(346)	(950)
Dividends paid on common stock	(3,001)	(2,585)
Other	(131)	(25)
Net cash provided by (used in) financing activities	(13)	(3,560)
Cash, cash equivalents and restricted cash:
Increase (decrease)	403	209
Balance at beginning of period	1,433	1,314
Balance at end of period	1,836	1,523
Cash, cash equivalents and restricted cash	$ 1,433	$ 1,523